home / stock / rgen / rgen short
Short Information | Repligen Corporation (NASDAQ:RGEN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,260,244 |
Total Actual Volume | 10,920,293 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 113,012 |
Average Short Percentage | 20.77% |
Is there a RGEN Short Squeeze or Breakout about to happen?
See the RGEN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-07-2024 | $168.34 | $167.72 | $169.215 | $165.99 | 529,350 | 109,669 | 20.72% |
05-06-2024 | $168.68 | $168.04 | $168.68 | $165.905 | 448,408 | 77,909 | 17.37% |
05-03-2024 | $170.1 | $167.05 | $172 | $166.43 | 454,984 | 75,218 | 16.53% |
05-02-2024 | $160.61 | $166.31 | $166.71 | $155.48 | 848,499 | 176,911 | 20.85% |
05-01-2024 | $159 | $158.36 | $164.15 | $151.82 | 909,295 | 150,579 | 16.56% |
04-30-2024 | $164.54 | $164.2 | $168.28 | $164.01 | 756,816 | 211,333 | 27.92% |
04-29-2024 | $167.91 | $166.14 | $168.96 | $163.22 | 426,055 | 83,708 | 19.65% |
04-26-2024 | $165.66 | $166.58 | $168.455 | $165.045 | 341,269 | 105,310 | 30.86% |
04-25-2024 | $166.21 | $165.66 | $168.105 | $163.23 | 238,746 | 40,851 | 17.11% |
04-24-2024 | $169.82 | $167.86 | $173.48 | $165.91 | 545,955 | 83,510 | 15.3% |
04-23-2024 | $166.49 | $171.28 | $174.3 | $165.435 | 928,604 | 204,830 | 22.06% |
04-22-2024 | $158.03 | $157.48 | $159.7 | $154.87 | 294,448 | 45,296 | 15.38% |
04-19-2024 | $157.63 | $157.14 | $159.41 | $156.33 | 386,770 | 86,055 | 22.25% |
04-18-2024 | $154.59 | $157.06 | $159.35 | $152.19 | 759,238 | 178,711 | 23.54% |
04-17-2024 | $165.22 | $160.98 | $169.2089 | $160.16 | 525,333 | 102,536 | 19.52% |
04-16-2024 | $165.96 | $164.17 | $166.21 | $160.91 | 609,323 | 159,020 | 26.1% |
04-15-2024 | $173.76 | $166.39 | $174.73 | $165.89 | 447,313 | 55,821 | 12.48% |
04-12-2024 | $174.01 | $171.53 | $174.615 | $169.74 | 706,402 | 88,473 | 12.52% |
04-11-2024 | $175.35 | $176.08 | $176.875 | $174.92 | 339,191 | 96,339 | 28.4% |
04-10-2024 | $176.43 | $176 | $177.925 | $175.02 | 424,294 | 128,165 | 30.21% |
News, Short Squeeze, Breakout and More Instantly...
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology...
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the following May investor conferences. RBC Capital Markets’ 2024 Global Hea...
Reports first quarter revenue of $151 million Increased new modalities revenue by 16% year-over-year Increased Filtration (non-COVID) revenue by 12% year-over-year Achieved a nine-month book-to-bill ratio of 1.03 WALTHAM, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Rep...